Thermo Fisher Scientific (TMO) Net Margin (2009 - 2026)

Thermo Fisher Scientific has disclosed Net Margin across 18 years of filings, most recently posting 15.06% for Q1 2026.

• Quarterly Net Margin rose 52.0% year-over-year to 15.06% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.3% (up 11.0% YoY) and the FY2025 annual result came in at 15.16%, up 38.0% from the prior year.
• Net Margin declined to 15.06% in Q1 2026, from 16.32% in the prior quarter.
• Over five years, Net Margin peaked at 18.74% in Q2 2022 and troughed at 12.04% in Q2 2023.
• A 5-year average of 14.84% and a median of 14.97% in 2023 frame the typical range for Net Margin.
• Biggest YoY gain for Net Margin was 222 bps in 2023; the steepest drop was 671 bps in 2023.
• Tracing TMO's Net Margin over 5 years: stood at 13.76% in 2022, then climbed by 9 bps to 14.97% in 2023, then increased by 7 bps to 16.06% in 2024, then grew by 2 bps to 16.32% in 2025, then retreated by 8 bps to 15.06% in 2026.
• Business Quant data shows TMO's Net Margin at 15.06% in Q1 2026, 16.32% in Q4 2025, and 14.49% in Q3 2025.